DRADS Capital is a Boston-based venture fund investing in life sciences, biotechnology, and A.I. companies focused on extending the boundaries of biomedical sciences. Our unique approach merges breakthrough science and technology from top academic laboratories and hospitals with strong leadership teams that are transforming how we treat and improve neurological health. Our portfolio of companies are unlocking human potential in treating neurodegenerative disease, improving mind-body wellness, and quantifying brain health.